Injection laryngoplasty for management of unilateral vocal fold paralysis

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 12, Issue 6, 2004, Pages 538-542

  Kwon, Tack Kyun ^a   Buckmire, Robert ^b,c  

^a Seoul National University Bundang Hospital   (South Korea)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c G0412 Neurosciences Hospital   (United States)

Author keywords

Autologous fascia; Calcium hydroxylapatite; Cymetra; Hyaluronic acid; Injection laryngoplasty; Larynx; Vocal fold paralysis

Indexed keywords

CALCIUM DERIVATIVE; COLLAGEN; FAT; GELFOAM; HYALURONIC ACID DERIVATIVE; HYDROXYAPATITE; POLITEF; SILICONE DERIVATIVE;

ATROPHY; BIOCOMPATIBILITY; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; FASCIA; GEL; GLOTTIS; HISTOCOMPATIBILITY; HUMAN; IMPLANT; INJECTION; LARYNGOPLASTY; LONGEVITY; MATERIAL STATE; NONHUMAN; PATIENT SELECTION; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SCAR FORMATION; SURGICAL TECHNIQUE; VOCAL CORD PARALYSIS;

ADJUVANTS, IMMUNOLOGIC; COLLAGEN; DURAPATITE; FASCIA; HUMANS; HYALURONIC ACID; PATIENT SELECTION; POLYTETRAFLUOROETHYLENE; PROSTHESES AND IMPLANTS; TRANSPLANTATION, AUTOLOGOUS; VOCAL CORD PARALYSIS;

EID: 9444255114     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.moo.0000144393.40874.98     Document Type: Review

References (18)

1. Bruening W: Uber eine neue Behandlungsmethode der Rekurrenslahmung. Verh Dtsch Laryngol 1911, 18:23.
2. Arnold GE: Vocal rehabilitation of paralytic dysphonia: cartilage injection into a paralyzed vocal cord. Arch Otolaryngol 1955, 62:1-17.
3. Rubin HJ: Pitfalls in treatment of dysphonia by intracordal injection of synthetics. Laryngoscope 1965, 75:1381-1397.
4. Homicz MR, Watson D. Review of injectable materials for soft tissue augmentation. Facial Plast Surg 2004, 1:21-29. An excellent organized review of material currently available for soft tissue augmentation.
5. Pearl AW, Woo P, Ostrowski R: A preliminary report on micronized AlloDerm injection laryngoplasty. Laryngoscope 2002, 112:990-996.
6. Karpenko AN, Dworkin JP, Meleca RJ, Stachler RJ. Cymetra injection for unilateral vocal fold paralysis. Ann Otol Rhinol Laryngol 2003, 112: 927-934. A prospective review of 10 patients with UVP treated by injection laryngoplasty with Cymetra.
7. Lundy DS, Casiano RR, McClinton ME, Xue JW: Early results of transcutaneous injection laryngoplasty with micronized acellular dermis versus type-I thyroplasty for glottic incompetence. J Voice 2003, 17:589-595. This study provides short-term follow-up data and comparison between paralysis patients treated with Cymetra injection versus type I thyroplasty.
8. Shindo ML, Zaretsky LS, Rice DH: Autologous fat injection for unilateral vocal fold paralysis. Ann Otol Rhinol Laryngol 1996, 105:602-606.
9. Glatz FR, Kalkanis J, Neumeister M, et al.: Volume analysis of preadipocyte injection for vocal cord medialization. Laryngoscope 2003, 113:1113-1117. This study offers a well-constructed, relatively long-term, prospective evaluation of volume retention after injection of a potential new injection laryngoplasty substrate. A concurrent lipoinjection control group adds valuable perspective to the volumetric outcome measure.
10. Rihkanen H: Vocal fold augmentation by injection of autologous fascia. Laryngoscope 1998, 108:51-54.
11. Rihkanen H, Reijonen P, Lehikoinen-Soderlund S, Lauri ER: Videostroboscopic assessment of unilateral vocal fold paralysis after augmentation with autologous fascia. Eur Arch Otorhinolaryngol 2004, 261:177-183. This paper offers an assessment of stroboscopic findings in a series of 14 patients following autologous fascia injection.
12. Rihkanen H, Kaliste E, Leivo I: Processing of fascia for vocal fold injection. A study in vitro and in paralyzed canine vocal folds. Ann Otol Rhinol Laryngol 2003, 112:729-733. An interesting investigation of the relative benefits of intraoperative mincing technique in the preparation of autologous fascia for injection laryngoplasty.
13. Chhetri DK, Jahan-Parwar B, Hart SD, et al.: Injection laryngoplasty with calcium hydroxylapatite gel implant in an in vivo canine model. Ann Otol Rhinol Laryngol 2004, 113:259-264. This publication offers important baseline, in vivo, 1-year data on the fate of a new injection material (CaHA) that is FDA approved for use in the human larynx.
14. Rosen CA, Thekdi AA: Vocal fold augmentation with injectable calcium hydroxylapatite: short-term results. J Voice, in press. This paper provides some important early insights and recommendations regarding the injection of CaHA into the human larynx while clinicians are just beginning to gain clinical experience with this material.
15. Dahlqvist A, Garskog O, Laurent C, et al.: Viscoelasticity of rabbit vocal folds after injection augmentation. Laryngoscope 2004, 114:138-142. This paper compares a relatively limited selection of the currently available augmentation substrates (collagen, Teflon, and hyaluronic acid derivatives) with regard to postinjection visco-elastic properties of the vocal fold.
16. Fernandez-Acenero MJ, Zamora E, Borbujo J: Granulomatous foreign body reaction against hyaluronic acid: report of a case after lip augmentation. Dermatol Surg 2003, 29:1225-1226. This is an important case report of a local soft tissue complication of hyaluronic acid despite its proposed nonantigenic properties.
17. Bernal-Sprekelsen M, Caballero M, Farre X, et al.: Particulate silicone for vocal fold augmentation: morphometric evaluation in a rabbit model. Ann Otol Rhinol Laryngol 2004, 113:234-241. This product, which is unavailable in the US, is proposed as another potential vocal fold augmentation material.
18. Kanemaru S, Nakamaru T, Omori K, et al.: Regeneration of the vocal fold using autologous mesenchymal stem cells. Ann Otol Rhinol Laryngol 2003, 112:915-920. The authors apply a fascinating and important novel approach to the problem of vocal fold regeneration. This preliminary, short-term data represents a burgeoning avenue of research and development for new injectable, autologous materials for voice rehabilitation.